about
Unmet needs in the prediction and detection of metastases in prostate cancer.Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group.The potential impact of adding genetic markers to clinical parameters in managing high-risk prostate cancer patients.Systemic GLIPR1-ΔTM protein as a novel therapeutic approach for prostate cancer.Antiproliferative effect of a synthetic aptamer mimicking androgen response elements in the LNCaP cell line.Diffusion-weighted MRI in early assessment of tumour response to radiotherapy in high-risk prostate cancer.Prostate stem cell antigen mRNA in blood is a predictor of survival after radical prostatectomy in patients with high-risk prostate cancer.
P2860
Q36871680-40AB0A70-A674-4961-8081-825C5B3B93AAQ37038406-4CF6159E-DBE8-401E-B952-19F1264CBAA9Q37170826-51F33B14-7EB1-427A-857F-638E9A38B141Q37618071-37C561DB-6C08-4D95-8062-3979C9C5A671Q38760586-A2C35A93-A572-45E0-B54D-9DED920D4AB6Q41881716-C4289D13-851E-483A-8777-497CF826CEA0Q55188158-6C47BE3A-CC45-488A-A523-72CB9AC92C2C
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Management of high-risk localized prostate cancer.
@ast
Management of high-risk localized prostate cancer.
@en
type
label
Management of high-risk localized prostate cancer.
@ast
Management of high-risk localized prostate cancer.
@en
prefLabel
Management of high-risk localized prostate cancer.
@ast
Management of high-risk localized prostate cancer.
@en
P2093
P2860
P356
P1433
P1476
Management of high-risk localized prostate cancer.
@en
P2093
Ariel E Marciscano
Matthew E Hardee
Nicholas Sanfilippo
P2860
P304
P356
10.1155/2012/641689
P577
2011-11-01T00:00:00Z